Tofacitinib
NDC 71656-071, Tofacitinib, solution, from Saptalis Pharmaceuticals, LLC..
- Product NDC
- 71656-071
- Status
- Listed
- Labeler
- Saptalis Pharmaceuticals, LLC.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218900
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71656-071 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/c6c033ff-bce0-4d1c-a182-3b13191686e1
Use it
Look up 71656-071 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71656-071 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71656-071. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.